$BXP

Evercore ISI Cuts Price Target on BXP to $65 From $67, Keeps In Line Rating

Evercore ISI reduced its price target for BXP from $67 to $65, maintaining an 'In Line' rating. JPMorgan also adjusted its target for BXP, lowering it from $87 to $81 while keeping an 'Overweight' rating. BXP's stock has declined 4.90% year-to-date and 12.02% over 5 days.

Original reporting
Published Oct 6, 2026, 11:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 12:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$BXP
Bearish
medium confidence
Mentioned
$BXP
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$BXPBearishLow
01

Why it matters

The downgrade could prompt short‑term selling pressure, though the unchanged rating may limit the reaction.

02

Market read

Analyst target adjustments are a routine catalyst for REITs; traders may adjust positions accordingly.

03

What to watch

Potential upside from upcoming property developments not reflected in the target.

Relevance 5/10Novelty 4/10Timing: post‑market release

Background

Evercore ISI provides research coverage on Boston Properties (BXP), a U.S. office REIT. The firm adjusted its valuation outlook, reducing the price target by $2 while keeping the rating unchanged.

Company-level read

Ticker impact

$BXPBearishMedium confidence
Context

Evercore ISI lowered its price target for Boston Properties to $65 from $67 and maintained an in‑line rating.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

The downgrade reflects a revised valuation view; no new corporate event, but it may influence short‑term sentiment.

Market effects

Minimal impact on REIT sector; similar analysts may follow suit.

U.S. REIT market only.

Limited to investors tracking Boston Properties.

Counterpoint

The target cut may be overly cautious if recent lease activity remains strong.

Key entities

  • Boston Properties

    U.S. office real estate investment trust (ticker BXP).

  • Evercore ISI

    Equity research analyst firm issuing the price‑target change.

Related articles

$BXPMedAI 8/10

Did BXP’s (BXP) Upbeat Q2 Beat and Higher FFO Outlook Just Shift Its Investment Narrative?

BXP reported Q2 2026 earnings exceeding expectations and raised its full-year FFO outlook, citing improved business fundamentals. The company's investment narrative hinges on high-quality office and life science space in key markets, with risks tied to new developments and leasing. BXP's $1.2B construction loan for 343 Madison Avenue highlights both potential and risks. Analysts' earnings estimates for 2029 range from $290.1M to $343.6M, with revenue projections between $3.7B and $3.8B.

$BXPMedAI 8/10

BXP's $1.2 Billion 343 Madison Loan Advances a Major Growth Project

BXP closed a $1.2B loan for its $2B 343 Madison Ave project, reducing equity needs to $341M. The 4-year loan at Term SOFR + 2.50% (declining to +2.25% upon milestones) funds 60% of costs. BXP targets 7.5%-8% returns, pending leasing and construction progress. The project is 50% pre-leased, with delivery expected in late 2029.

$BXPMed

BXP, Inc. Q2 2026 Earnings Call Summary

Strategic Performance and Market Dynamics BXP delivered a strong second quarter, exceeding FFO guidance by $0.08 and raising the 2026 midpoint by $0.05, driven by faster-than-expected leasing and occupancy gains. Management attributes the leasing momentum to a 'very healthy environment' for premier workplaces, noting that AI is acting as a significant tailwind by driving space expansions and upgrades among tech and professional service firms.

$BXPMed

BXP Secures $1.2B Construction Loan for 343 Madison Avenue Office Tower – Commercial Observer

BXP announced it secured a $1.2B construction loan for its 930,000 sq ft, 46-story office tower at 343 Madison Ave in Midtown, with a four-year term plus a one-year extension option, from Wells Fargo, Bank of America Securities, BNY Mellon and J.P. Morgan. Completion is set for 2029; the project is 50% pre-leased. BXP reported Q2 2026 FFO of $283.4M ($1.78/share) and revenue of $895.7M.

$BXPMed

BXP Selling 7 Times Square Ground Lease

Boston Properties (BXP) is marketing the 7 Times Square ground lease via Eastdil Secured, hiring Will Silverman and Gary Phillips. BXP expects proceeds of $700 million to $750 million, with bids due soon. The 1.2M sq ft tower has a 99-year lease and is 91% occupied. The deal would test Times Square office demand.